Tim Kong, MD PhD

Cancer researcher and internal medicine resident @WeillCornell | via @WUSTLmed MSTP and @mcgillu

[Elizabeth McKenna @ElizSMcKenna]

ICYMI in @CD_AACR: Molecular and Structural Basis of Pan-Resistance to BTK Degraders and Inhibitors - by @QuinlanSievers, Hao Lu, Alison Cool, @TaylorJ_MD, @MCThompsonMD, Gwenn Hansen, @AbdelWahablab, and colleagues @MSKCancerCencer @Nurix_Tx @univmiami

[Tim Kong, MD PhD @TimKongMDPhD]

Congratulations to @QuinlanSievers and all of the collaborators on this important work. These findings provide valuable insights that will help inform the development and optimization of next-generation BTK inhibitors. Thanks for the opportunity to contribute to this project!

[Abdel-Wahab Lab @AbdelWahablab]

Excited to announce a new paper out today in @CD_AACR on clinical mechanisms of resistance to BTK degraders. Led by @QuinlanSievers & our ongoing collaboration with @MCThompsonMD, @Nurix_Tx, & @TaylorJ_MD (U. Miami):
https://t.co/0Rm2fNdeih

[Stephen Oh @mpndoc]

Super thrilled to share our latest effort "Galectin-1 Fuels Monocyte Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative Neoplasms" now online in Blood! 🤩

@ASH_hematology @BloodPortfolio
@WashUHematology @WashUDeptMed

https://t.co/pG9QkSOZmU

[Tim Kong, MD PhD @TimKongMDPhD]

Appreciative of @WeillCornell for supporting resident wellness after four weeks of cards floor and two weeks of nights. Great to be at the @nyknicks game and seeing them dominate!

[Tim Kong, MD PhD @TimKongMDPhD]

New institution, same affinity for running gels #leuklabafterleukconsults #noflowforme @WeillCornell @MSKCancerCenter

[Tim Kong, MD PhD @TimKongMDPhD]

@nsarellano9 @mpndoc @WashUHematology @WashUDeptMed @washumedicine You guys are also invited 😛

[Tim Kong, MD PhD @TimKongMDPhD]

@TheElfLab @mpndoc @WashUDeptMed @WashUHematology @nsarellano9 sorry you have to deal with this

[Stephen Oh @mpndoc]

🎉 Honored to be recognized at the Outstanding Faculty and Staff Awards & inspired by the testimonials from the student nominators who spoke of the impact each awardee had on their professional & personal development. 🙏🏼 @TimKong_ for nominating me for this award!

[Tim Kong, MD PhD @TimKongMDPhD]

@mpndoc @WashUDeptMed @WashUHematology Well deserved! #proudmentee

[Tim Kong, MD PhD @TimKongMDPhD]

@mpndoc @TheElfLab @AmiBPatelMD @tylerm_parso @MBrakhane @shu_lin1 #bestmentorever

[Tim Kong, MD PhD @TimKongMDPhD]

@mpndoc pain

[Stephen Oh @mpndoc]

Thrilled to share our study now online @BloodJournal dissecting the role of NFκB signaling effectors in MPN disease biology! #mpnsm #IRAKs @WashUHeme @WUDeptMedicine @WashUDPS https://t.co/l129THRP8j 1/

[Stephen Oh @mpndoc]

Delighted to share our latest effort leveraging MPN patient samples, CRISPR-engineered hPSC lines, and PDX modeling to uncover unique interactions between mutant JAK2 and ASXL1 modulating erythropoiesis in MPNs! https://t.co/herLtiOF6L @WashUHeme #mpnsm

[Tim Kong, MD PhD @TimKongMDPhD]

@TheElfLab I see @mpndoc #retiredhands

[Stephen Oh @mpndoc]

Beyond thrilled to share our collaborative Oh/Di Paola labs study led by the amazing Fan He uncovering a previously unrecognized metabolic disorder in MPN platelets now online @jclinicalinvest! @WashUHeme @WUDeptMedicine @WashUDPS #mpnsm
https://t.co/ewb7SnykZQ

[Stephen Oh @mpndoc]

Pleased to share our latest study "Comprehensive profiling of clinical JAK inhibitors in myeloproliferative neoplasms" led by @WUSTLmstp @WashUCancerBio student @TimKong_ now online @AjHematology! @WashUHeme @WashUDPS #mpnsm #inflammation #hepcidin https://t.co/L4dCZ3zNiV 1/

[WashU Medicine Radiation Oncology @WashUMedRadOnc]

The lab of @CarlDeSelm has been very busy! Two new publications-one reporting on use of low dose radiation to improve #leukemia #lymphoma response to CAR T-cell therapy & other reports first CAR macrophage therapy for #Alzheimers.
https://t.co/BzhVkcYjwi
https://t.co/BtJ4ezUWEY

[Stephen Oh @mpndoc]

Deepest gratitude to @ale_baldu & @lizzyg100 for the opportunity to share our collaborative studies with @DipaolaJorge led by @Fan_He_MPN_PLT @GordonConf #megakaryocytes #platelets! Check out our preprint on this work: https://t.co/fFEq4dxxSS

[Stephen Oh @mpndoc]

🚨Just under the wire before the end of 2022, we are thrilled to announce our manuscript out today @NatureCancer “DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression"! @TimKong_ @challenlab @HmzaCelik @HuangLabMcGill @WashUHeme 1/ https://t.co/71fVQgA0aI